Waft Pharma Private Limited

Waft Pharma Private Limited - pharma in Rajamahendravaram, Andhra Pradesh, India. FY 2026 financials and compliance.
CIN U33100AP2017PTC106922 Incorporated 26 October 2017 ROC Vijayawada HQ Rajamahendravaram, Andhra Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2022
₹30.37 Lakh
▲ 4519.00% YoY
EBITDA · FY 2022
Locked
In full report
Net profit · FY 2022
Locked
In full report
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
9 yrs
Est. 2017
Last financials
Mar 2022
Balance sheet date

About Waft Pharma Private Limited

Data last updated: 07 March 2026

Waft Pharma Private Limited is a private limited company based in Rajamahendravaram, Andhra Pradesh, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 26 October 2017, the company has been in operation for over 9 years.

Registered with ROC Vijayawada under CIN U33100AP2017PTC106922.

Capital: an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Venkata Subbarao Gidugu and Venkata Ramaiah Tumati.

Last AGM: 30 September 2022. Financial statements filed for year ended 31 March 2022. Office: Rajamahendravaram, Andhra Pradesh.

As per the financials filed for FY 2022, the company reported a revenue of ₹30.37 Lakh, reflecting significant growth compared to the previous year.

The company is associated with 1 brand - Waft Pharma.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website waftpharma.com.

Company Details of Waft Pharma Private Limited
CIN U33100AP2017PTC106922
Registration Number 106922
Incorporation Date 26 October 2017
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    74 – 2 – 5/1 1St Floor Opposite Niveditha Kishore Public School Addepalli Colony Ava Roa, D, Rajamahendravaram, Andhra Pradesh, India – 533103
  • Industry
    Pharma, Drug Formulation & Development
Company report
Waft Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Waft Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Waft Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Waft Pharma Private Limited

Waft Pharma Private Limited operates one associated brand: WAFT Pharma. These brands represent Waft Pharma Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Develops and manufactures a range of pharmaceutical products, including tablets, capsules, syrups, liquids, ointments, and injections. waftpharma.com

Competitors & Alternatives of Waft Pharma Private Limited

Brands and companies operating in the same space as Waft Pharma Private Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.

Competitor Description Location Founded
Jubilant Life Sciences Jubilant Life Sciences Company offering a suite of R&D and manufacturing services for small molecules and generics Noida, India, India 1978
Akums Akums CDMO focusing on spectrum of dosage forms and therapeutic segments Delhi, India, India 2004
Nectar Lifesciences Nectar Lifesciences Cephalosporin APIs and generic formulations are manufactured. Chandigarh, India, India 1995
Windlas Windlas Biopharma regulatory affairs, quality control, and strategy services are provided. Gurugram, India, India 2001
Unither Unither Contract development and manufacturing organization for proprietary and generic drugs Paris, France, France 1993
Recipharm Recipharm Pharmaceutical development and manufacturing services are offered contractually. Jordbro, Sweden, Sweden 1995
CoreRx CoreRx CDMO with a focus on early phase drug product development Clearwater, United States, United States 2006
MedPharm MedPharm Topical and inhaled drug delivery formulations are developed and manufactured. Guildford, United Kingdom, United Kingdom 1998

Business Activity of Waft Pharma Private Limited

Waft Pharma Private Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including other hospital and medical care activities.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Q Hospital and Medical Care Q6 Other Hospital and Medical Care Activities Locked
Premium access

Business activity turnover details for Waft Pharma Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Waft Pharma Private Limited

Auditor information for Waft Pharma Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.

Board of Directors of Waft Pharma Private Limited

Waft Pharma Private Limited is currently managed by 5 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Venkata Subbarao Gidugu Director 21 Oct 2020 5 Years 9 Months Current
Venkata Ramaiah Tumati Director 31 Mar 2018 8 Years 4 Months Current
Surya Chandra Sekhara Rao Samsani Director 26 Oct 2017 8 Years 9 Months Current
Sai Dileep Viswanadha Director 26 Oct 2017 8 Years 9 Months Current
Santhi Sree Tumati Director 26 Oct 2017 8 Years 9 Months Current

Financials of Waft Pharma Private Limited FY 2022 filings available

Waft Pharma Private Limited reported revenue of ₹30.37 Lakh (up 4519.00% YoY) for FY 2022.

Revenue · FY 2022
₹30.37 Lakh ▲ 4519.00%
Premium access

Ten-year financial statements for Waft Pharma Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Waft Pharma Private Limited

Premium access

Shareholding and ownership data for Waft Pharma Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Waft Pharma Private Limited

Waft Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Waft Pharma Private Limited

View historical data on people associated with Waft Pharma Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Waft Pharma Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Waft Pharma Private Limited

Premium access

GST registrations and filing compliance for Waft Pharma Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Waft Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Waft Pharma Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Waft Pharma Private Limited

Premium access

MSME payment history for Waft Pharma Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Waft Pharma Private Limited

Premium access

Corporate group structure for Waft Pharma Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Waft Pharma Private Limited

Premium access

MCA filings and documents for Waft Pharma Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Waft Pharma Private Limited

Activity
30 Sep 2022
Waft Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Activity
31 Mar 2022
Waft Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Vijayawada.
Directors
21 Oct 2020
Venkata Subbarao Gidugu was appointed as a Director on 21 Oct 2020 & has been associated with this company since 5 years 9 months.
Directors
31 Mar 2018
Venkata Ramaiah Tumati was appointed as a Director on 31 Mar 2018 & has been associated with this company since 8 years 4 months.
Directors
26 Oct 2017
Surya Chandra Sekhara Rao Samsani was appointed as a Director on 26 Oct 2017 & has been associated with this company since 8 years 9 months.
Directors
26 Oct 2017
Sai Dileep Viswanadha was appointed as a Director on 26 Oct 2017 & has been associated with this company since 8 years 9 months.

Frequently Asked Questions about Waft Pharma Private Limited

Waft Pharma Private Limited is an active private limited company in the pharma sector based in Rajamahendravaram, Andhra Pradesh, India. It was incorporated on 26 October 2017 (9+ years old) and is registered under CIN U33100AP2017PTC106922.

Waft Pharma Private Limited reported revenue of ₹30.37 Lakh for FY 2022 (up 4519.00% YoY).

The current directors of Waft Pharma Private Limited are:

The primary industry of Waft Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Waft Pharma Private Limited can be reached at the registered office: 74 – 2 – 51 1St Floor Opposite Niveditha Kishore Public School Addepalli Colony Ava Roa, D, Rajamahendravaram, Andhra Pradesh, India – 533103, or through the website waftpharma.com.

The authorised capital is ₹20 Lakh, and the paid-up capital is ₹20 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available